Market revenue in 2023 | USD 119.1 million |
Market revenue in 2030 | USD 207.4 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.36% in 2023. Horizon Databook has segmented the India clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
India is one of the world’s rapidly growing pharmaceutical markets. Major factors boosting the growth of supply chain management include product proliferation, quality & regulatory issues, infrastructure gaps, and supply chain fragmentation.
The pharmaceutical supply chain management in India is facing challenges with end-to-end complexity. Reducing this complexity may lead to various advantages. This factor is largely contributing to the growth of the clinical trial supply and logistics market.
Furthermore, there has been a steady rise in the number of clinical trials performed in the region in recent years. In 2018, George Clinical announced that India is poised to become “one of the largest clinical trial hubs.
Horizon Databook provides a detailed overview of country-level data and insights on the India clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into India clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account